Zion Market Research.jpg
Global Brain-Computer Interface Market Size Astounding Growth to $6100 Billion by 2030, Growing at a CAGR of 16.5%
05 sept. 2023 14h33 HE | Zion Market Research
New York, NY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Brain-Computer Interface Market By Product (Invasive BCI, Partially Invasive BCI,...
Logo transparent PNG.png
PathMaker Neurosystems Receives $200,000 START Award from MassVentures
05 juin 2023 06h00 HE | PathMaker Neurosystems Inc.
BOSTON, June 05, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
emotiv-logo-ol (2).png
EMOTIV Enlists Two Machine Learning Heavyweights as AI Takes Aim at the Human Brain
01 mai 2023 09h00 HE | Emotiv Inc.
SAN FRANCISCO, May 01, 2023 (GLOBE NEWSWIRE) -- EMOTIV, the bioinformatics pioneer advancing understanding of the human brain using electroencephalography (EEG), today added two renowned scientists...
22157.jpg
Neurotech Devices Global Market Outlook Report 2023: Market Revenue Data for 2021, Estimates for 2022, 2023, 2025, and CAGR Projections through 2027
14 févr. 2023 09h38 HE | Research and Markets
Dublin, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The "Neurotech Devices: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. In this report, the market is segmented based...
MyoRegulator® ALS device
Muscular Dystrophy Association Awards Venture Philanthropy Funding to PathMaker Neurosystems to Develop Neuromodulation Treatment for ALS
17 janv. 2023 06h00 HE | PathMaker Neurosystems Inc.
BOSTON and NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company...
22157.jpg
Global Neurotechnology Market Report 2022: The Definitive Report on Neuromodulation, Neuroprosthetics, Neurodiagnostics, and Neurorehabilitation Devices
10 août 2022 05h13 HE | Research and Markets
Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "The Market for Neurotechnology: 2022-2026" report has been added to ResearchAndMarkets.com's offering. Overall worldwide market for neurotechnology...
22157.jpg
Global Invasive Brain-Computer interface (BCI) Market Research Report 2022: Real-time Decoding of Macroscopic Brain States Becomes Critical
14 juin 2022 05h43 HE | Research and Markets
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Market Overview of Invasive Brain-Computer interface (BCI)" report has been added to ResearchAndMarkets.com's offering. Patients with Locked-in...
Logo transparent PNG.png
PathMaker Neurosystems Initiates U.S. Multi-Center Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
07 mars 2022 06h00 HE | PathMaker Neurosystems Inc.
BOSTON and PARIS, March 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Logo transparent PNG.png
PathMaker Neurosystems Appoints Leading Neurotechnology Expert, John Donoghue, Ph.D., to Board of Directors
21 oct. 2021 05h00 HE | PathMaker Neurosystems Inc.
BOSTON and PARIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Heuro-Logo-white-tag.png
Heuro Canada First to Bring Revolutionary Neurological Health Technology to Canada
07 déc. 2018 05h00 HE | Heuro Canada
SURREY, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Heuro Canada Inc., a leading provider of innovative neurological health solutions, is championing a new therapeutic paradigm for...